Skip to content

Pilot study into the validity and usability of the DynMetrics gait analysis system.

Pilot study into the validity and usability of the DynMetrics gait analysis system. - Validity and usability DynMetrics.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46512
Enrollment
15
Registered
2018-06-08
Start date
2018-06-11
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

None listed

Sponsors

Revalidatiecentrum Het Roessingh
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Reliability - Understand Dutch or English; - Able to follow simple instructions; - Experience mobility-related walking problems (FAC score between 3 and 5, as determined by the treating physiotherapist).;Usability - Work as a physiotherapist at Roessingh, Center for Rehabilitation - Treating stroke survivors, either in- or outpatient

Exclusion criteria

Exclusion criteria: Validity - Require physical support of a physiotherapist during walking (the DynMetrics system might encounter problems when two bodies are so close together that they are hard to distinguish from one another); - Are using a stroller (this might obscure the foot positioning which would be problematic for the DynMetrics system).;Usability No specific exclusion criteria

Design outcomes

Primary

MeasureTime frame
For the validity part, the main study parameter is the intraclass correlation coefficient of the data from the DynMetrics system and the Vicon system. For the usability part, the main study parameter is the usability of the DynMetrics system as quantified by the System Usability Scale.

Secondary

MeasureTime frame
For the validity part, see primary study parameters. For the usability part, the main study parameter is the usability of the DynMetrics system as quantified by a semi-structured interview.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)